• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心内膜炎患者 30 天再入院的预测因素:一项全国基于人群的队列研究。

Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study.

机构信息

Division of Cardiology, Department of Internal Medicine, Emory University, Atlanta, GA 30322, USA.

Division of Cardiology, Department of Internal Medicine, Einstein Medical Center, Philadelphia, PA 19141, USA.

出版信息

Rev Cardiovasc Med. 2020 Mar 30;21(1):123-127. doi: 10.31083/j.rcm.2020.01.552.

DOI:10.31083/j.rcm.2020.01.552
PMID:32259911
Abstract

Infective endocarditis (IE) is a life threatening disease requiring lengthy hospitalizations, complex multidisciplinary management and high health care costs. In this study, we analyzed the National Readmissions' Database (NRD) to identify infective endocarditis cases and the causative organisms, clinical determinants, length of stay, in-hospital mortality, and 30-day hospital readmission rates. The study cohort was derived from Healthcare Cost and Utilization Project's National Readmission Database between 2010-15. We queried the National Readmissions' Database using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnostic code for infective endocarditis (421.0) and identified a total of 187,438 index admissions. SAS 9.4 (SAS Institute Inc., Cary, NC) was utilized for statistical analyses. A total of 187,438 patients with a primary diagnosis of IE were identified over 6 years (2010-2015). Twenty-four percent (44,151 patients) were readmitted within 30 days. Most common etiologies for readmission included sepsis (14%), acute heart failure (8%), acute kidney injury (6%), intracardiac device infection (5.6%) and recurrence of IE (2.7%). Predictors of increased readmissions included female sex, staphylococcus aureus infection, diabetes, chronic lung disease, chronic liver disease, acute kidney injury, acute heart failure and anemia. In-hospital mortality for the readmission of IE was 13%, and average length of stay during the re-admission was 12 days. IE is associated with high rates of index admission mortality and for 30-day readmissions of which are associated with a substantial risk of death.

摘要

感染性心内膜炎(IE)是一种危及生命的疾病,需要长时间住院治疗、复杂的多学科管理和高昂的医疗保健费用。在这项研究中,我们分析了国家再入院数据库(NRD),以确定感染性心内膜炎病例和病原体、临床决定因素、住院时间、住院死亡率以及 30 天内再入院率。研究队列来自医疗保健成本和利用项目的国家再入院数据库,时间为 2010-15 年。我们使用国际疾病分类,第九修订版,临床修正(ICD-9-CM)诊断代码 421.0 对感染性心内膜炎进行了全国再入院数据库查询,共确定了 187438 例索引入院。SAS 9.4(SAS Institute Inc.,Cary,NC)用于统计分析。在 6 年内(2010-2015 年)共确定了 187438 例原发性 IE 患者。24%(44151 例)在 30 天内再次入院。再入院最常见的病因包括败血症(14%)、急性心力衰竭(8%)、急性肾损伤(6%)、心内装置感染(5.6%)和 IE 复发(2.7%)。再入院增加的预测因素包括女性、金黄色葡萄球菌感染、糖尿病、慢性肺病、慢性肝病、急性肾损伤、急性心力衰竭和贫血。IE 再入院的住院死亡率为 13%,再入院期间的平均住院时间为 12 天。IE 与较高的指数入院死亡率相关,30 天内再入院与死亡风险显著相关。

相似文献

1
Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study.感染性心内膜炎患者 30 天再入院的预测因素:一项全国基于人群的队列研究。
Rev Cardiovasc Med. 2020 Mar 30;21(1):123-127. doi: 10.31083/j.rcm.2020.01.552.
2
Thirty-Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database.感染性心内膜炎 30 天后再入院:来自全国再入院数据库的分析。
J Am Heart Assoc. 2019 May 7;8(9):e011598. doi: 10.1161/JAHA.118.011598.
3
Predictors of 90-Day Readmission and in-Hospital Mortality in Takotsubo Cardiomyopathy: An Analysis of 28,079 Index Admissions.应激性心肌病90天再入院率及院内死亡率的预测因素:对28079例首次入院病例的分析
Cardiovasc Revasc Med. 2019 Nov;20(11):973-979. doi: 10.1016/j.carrev.2019.08.004. Epub 2019 Aug 13.
4
Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.全国范围内间歇性跛行和严重肢体缺血患者再入院因素
Ann Vasc Surg. 2018 Oct;52:96-107. doi: 10.1016/j.avsg.2018.03.011. Epub 2018 May 17.
5
Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations.房颤住院患者再入院的结局和资源利用情况。
J Am Heart Assoc. 2019 Oct;8(19):e013026. doi: 10.1161/JAHA.119.013026. Epub 2019 Sep 19.
6
Outcomes of Cardiac Arrest with Valve Surgery Among Infective Endocarditis Patients: A United States National Cohort Study.感染性心内膜炎患者心脏骤停伴瓣膜手术的结局:一项美国全国队列研究。
Cardiovasc Revasc Med. 2023 Apr;49:49-53. doi: 10.1016/j.carrev.2022.11.004. Epub 2022 Nov 11.
7
Trends, etiologies, and predictors of 90-day readmission after percutaneous ventricular assist device implantation: A national population-based cohort study.经皮心室辅助装置植入术后90天再入院的趋势、病因及预测因素:一项基于全国人群的队列研究。
Clin Cardiol. 2018 May;41(5):561-568. doi: 10.1002/clc.22929. Epub 2018 May 10.
8
Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis.脓毒症患者 30 天再入院的流行病学和预测因素。
Chest. 2019 Mar;155(3):483-490. doi: 10.1016/j.chest.2018.12.008.
9
Etiologies, Trends, and Predictors of 30-Day Readmissions in Patients With Diastolic Heart Failure.舒张性心力衰竭患者30天再入院的病因、趋势及预测因素
Am J Cardiol. 2017 Aug 15;120(4):616-624. doi: 10.1016/j.amjcard.2017.05.028. Epub 2017 Jun 1.
10
Readmissions in ST-Elevation Myocardial Infarction and Cardiogenic Shock (from Nationwide Readmission Database).ST 段抬高型心肌梗死和心原性休克再入院(来自全国再入院数据库)。
Am J Cardiol. 2019 Dec 15;124(12):1841-1850. doi: 10.1016/j.amjcard.2019.08.048. Epub 2019 Sep 26.

引用本文的文献

1
Anemia and Transfusion in Infective Endocarditis.感染性心内膜炎中的贫血与输血
Rev Cardiovasc Med. 2025 Jun 23;26(6):33394. doi: 10.31083/RCM33394. eCollection 2025 Jun.
2
Postoperative Treatment Regimens in Patients With Native Valve Endocarditis due to Who Undergo Valve Replacement or Repair.因[具体病因未给出]接受瓣膜置换或修复的自体瓣膜心内膜炎患者的术后治疗方案。
Open Forum Infect Dis. 2025 Mar 26;12(4):ofaf179. doi: 10.1093/ofid/ofaf179. eCollection 2025 Apr.
3
Polyphenols could be Effective in Exerting a Disinfectant-Like Action on Bioprosthetic Heart Valves, Counteracting Bacterial Adhesiveness.
多酚可能对生物人工心脏瓣膜发挥类似消毒剂的作用,抵消细菌粘附力。
Cardiol Cardiovasc Med. 2022;6(5):487-492. doi: 10.26502/fccm.92920287. Epub 2022 Sep 30.
4
Epidemiologic and clinical characteristics of infective endocarditis: a single-center retrospective study in the Bronx, New York.感染性心内膜炎的流行病学和临床特征:纽约布朗克斯的单中心回顾性研究。
Infection. 2022 Oct;50(5):1349-1361. doi: 10.1007/s15010-022-01846-3. Epub 2022 May 25.
5
Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre.感染性心内膜炎患者的死亡率和不良事件的预测因素:外科中心的回顾性真实世界研究。
BMC Cardiovasc Disord. 2021 Jan 12;21(1):28. doi: 10.1186/s12872-021-01853-6.
6
Endocarditis in Patients with Aortic Valve Prosthesis: Comparison between Surgical and Transcatheter Prosthesis.主动脉瓣人工瓣膜患者的心内膜炎:外科人工瓣膜与经导管人工瓣膜的比较
Antibiotics (Basel). 2021 Jan 6;10(1):50. doi: 10.3390/antibiotics10010050.